Sickle Cell Uric Acid (SCUA) - Cohort Repository
NCT04190888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2022-02-04
Summary
The purpose of this research is to study the causes of Sickle Cell kidney disease, as well as to collect and store samples and information about people with Sickle Cell Disease.
Conditions
- Chronic Kidney Diseases
- Sickle Cell Disease
Interventions
- OTHER
-
No intervention
No intervention - observational study
Sponsors & Collaborators
-
Virginia Commonwealth University
lead OTHER
Principal Investigators
-
Cristin Kaspar, MD · Virginia Commonwealth University
Eligibility
- Min Age
- 5 Years
- Max Age
- 29 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])
NCT00529061 ·Status: TERMINATED
-
Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277 ·Status: COMPLETED
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
NCT01800526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
NCT00495638 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa
NCT05681598 ·Status: COMPLETED ·Phase: NA
-
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 ·Status: TERMINATED
-
Sickle Cell Kidney Biorepository
NCT07064174 ·Status: RECRUITING
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED
-
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327 ·Status: COMPLETED
-
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
NCT05285917 ·Status: RECRUITING ·Phase: PHASE3
-
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
NCT03288012 ·Status: UNKNOWN
-
Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
NCT00639392 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
NCT06699849 ·Status: RECRUITING ·Phase: PHASE2
-
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799 ·Status: COMPLETED
-
Neutrophil Extracellular Traps and Sickle Cell Disease
NCT02004808 ·Status: UNKNOWN
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease
NCT05407740 ·Status: COMPLETED
-
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
NCT00350844 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
NCT00001197 ·Status: COMPLETED ·Phase: PHASE2
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED
-
A Study to Learn About Sickle Cell Disease In Adult Patients
NCT05407805 ·Status: COMPLETED
-
Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005326 ·Status: COMPLETED